David R. Bauer
Lawyers
Filters
Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
GE Vernova $2.6 billion debut senior notes offering
We advised the representatives of the underwriters on the offering
Maze Therapeutics $200 million at-the-market offering
We advised the sales agent on the offering
Perspective Therapeutics $175 million equity offering
We advised the representatives of the underwriters on the transaction
EquipmentShare $860 million IPO
We advised EquipmentShare on its IPO
AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca
We advised AbelZeta on the transaction
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
W. L. Gore & Associates acquisition of Conformal Medical
We are advising Gore on the transaction
GSK strategic collaboration with CAMP4 Therapeutics
We advised GSK on the transaction